Medicare Enrolled

Dr. Georges Dagher, M.D.

Cardiovascular Disease · Safety Harbor, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1840 MEASE DR STE 200, Safety Harbor, FL 34695
7277248611
In practice since 2007 (18 years)
NPI: 1023234242 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dagher from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dagher? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dagher

Dr. Georges Dagher is a cardiovascular disease in Safety Harbor, FL, with 18 years in practice. Based on federal Medicare data, Dr. Dagher performed 4,364 Medicare services across 3,130 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dagher received a total of $4,927 from 23 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dagher is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 25% volume in FL$ $4,927 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,364
Medicare services
Top 25% in FL for cardiovascular disease
3,130
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~242 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)942$89$311
Hospital follow-up visit, high complexity640$94$257
EKG interpretation and report628$6$20
Initial hospital admission, high complexity307$133$498
Echocardiogram, transthoracic285$142$478
Electrocardiogram (EKG), 12-lead252$10$35
Regadenoson injection (Lexiscan) for heart stress test194$44$174
Technetium tc-99m tetrofosmin, diagnostic, per study dose174$342$1,079
Prothrombin time test (blood clotting)154$4$10
Nuclear medicine studies of heart muscle at rest and with stress and spect88$332$1,036
New patient office visit (45-59 min)74$115$409
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician72$11$35
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician67$16$50
Exercise or drug-induced heart stress test with electrocardiogram (ecg)67$20$85
Office visit, established patient (20-29 min)63$62$221
Ultrasound study of arm or leg veins with compression and maneuvers57$137$449
Ultrasound of both sides of head and neck blood flow41$131$458
Office visit, established patient (10-19 min)40$37$162
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional32$20$63
Ultrasound of heart with color-depicted blood flow, rate and valve function23$17$55
New patient office visit (30-44 min)21$75$276
Ultrasound of heart with probe in esophagus, with report20$83$271
Ultrasound of heart blood flow, valves and chambers20$39$120
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report20$176$554
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician19$45$168
External shock to heart to regulate heart beat15$85$266
Ultrasound of heart, follow-up14$19$63
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional12$18$162
Injection, sulfur hexafluoride lipid microspheres, per ml12$13$589
New patient office visit, complex (60-74 min)11$143$445
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.5% high complexity
15.4% medium
77.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,927
Total received (2018-2024)
Avg $704/year across 7 years
Top 40% in FL for cardiovascular disease
23
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,927 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$457
2023
$333
2022
$438
2021
$358
2020
$217
2019
$1,756
2018
$1,370

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$653
E.R. Squibb & Sons, L.L.C.
$632
Amgen Inc.
$583
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$516
AstraZeneca Pharmaceuticals LP
$508
Novartis Pharmaceuticals Corporation
$439
CVRx, Inc.
$313
Boehringer Ingelheim Pharmaceuticals, Inc.
$307
Abbott Laboratories
$271
Boston Scientific Corporation
$177
Janssen Pharmaceuticals, Inc
$161
Amarin Pharma Inc.
$106
Medtronic Vascular, Inc.
$60
United Therapeutics Corporation
$38
Astellas Pharma US Inc
$23
SANOFI-AVENTIS U.S. LLC
$23
Daiichi Sankyo Inc.
$21
Philips Electronics North America Corporation
$20
Gilead Sciences, Inc.
$19
Medtronic, Inc.
$17
iRhythm Technologies, Inc.
$17
Kowa Pharmaceuticals America, Inc.
$11
Chiesi USA, Inc.
$11
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
(5044) MCOT · 3F · Adapta · BRILINTA · BYDUREON · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · INJECTAFER · JARDIANCE · LEXISCAN · LifeVest · Livalo · Mitra Clip system · ORENITRAM · PRADAXA · PRALUENT · Repatha · Reveal LINQ · VYNDAQEL · Varithena Administration Pack · Vascepa · WATCHMAN · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $113 per 100 Medicare services performed
Looking for a cardiovascular disease in Safety Harbor?
Compare cardiovascular diseases in the Safety Harbor area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
224
Per 100K population
23.3
County median income
$70,293
Nearest hospital
MEASE COUNTRYSIDE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dagher is a clinical cardiology specialist, with above-average Medicare volume (top 25% in FL), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dagher experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dagher performed 942 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dagher receive payments from pharmaceutical companies?
Yes. Dr. Dagher received a total of $4,927 from 23 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dagher's costs compare to other cardiovascular diseases in Safety Harbor?
Dr. Dagher's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dagher) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →